Presentation Operator Message
Operator (Operator)
Good day, and thank you for standing by. Welcome to the results of LEGEND Phase II combination trial with lanifibranor and Empagliflozin in patients
I
|
Marché Fermé -
Euronext Paris
17:55:00 18/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 3,230 EUR | -2,56% |
|
-5,00% | -18,12% |
| 16/09 | Transcript : Inventiva S.A. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 04:50 PM | |
| 11/09 | Paris prend un peu de hauteur avant l'inflation américaine | AW |
Publié le 19/03/2024 à 13:00
Presentation Operator Message
Operator (Operator)
Good day, and thank you for standing by. Welcome to the results of LEGEND Phase II combination trial with lanifibranor and Empagliflozin in patients
I
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national